Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from American Society of Breast Surgeons, Society of Breast Imaging, and College of American Pathology 2026 Guidelines for the Management of Proliferative Lesions With Atypia and Lobular Carcinoma In Situ. Local targets link to admitted publications; unresolved targets remain external evidence.
American Society of Breast Surgeons and Society of Breast Imaging 2025 guidelines for the management of benign breast fibroepithelial lesions.
10.1001/jamasurg.2025.4392 · 2025 · External reference
The Tyrer-Cuzick model inaccurately predicts invasive breast cancer risk in women with LCIS.
10.1245/s10434-019-07814-w · 2020 · External reference
Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk.
10.1200/jco.2015.61.4743 · 2015 · External reference
Accuracy of the breast cancer surveillance consortium model among women with LCIS.
10.1007/s10549-021-06499-8 · 2022 · External reference
Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
10.1093/jnci/dji372 · 2005 · External reference
Population-based analysis of breast cancer incidence and survival outcomes in women diagnosed with lobular carcinoma in situ.
10.1245/s10434-017-5867-6 · 2017 · External reference
Atypical hyperplasia of the breast–risk assessment and management options.
10.1056/nejmsr1407164 · 2015 · External reference
Stratification of breast cancer risk in women with atypia: a Mayo cohort study.
10.1200/jco.2006.09.0217 · 2007 · External reference
Histological features associated with diagnostic agreement in atypical ductal hyperplasia of the breast: illustrative cases from the B-Path study.
10.1111/his.13035 · 2016 · External reference
Ductal epithelial proliferations of the breast: a biological continuum? comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.
10.1002/path.982 · 2001 · External reference
Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors.
10.1002/path.1973 · 2006 · External reference
Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family.
10.1097/pas.0b013e318161d1a5 · 2008 · External reference
Breast cancer precursors revisited: molecular features and progression pathways.
10.1111/j.1365-2559.2010.03568.x · 2010 · External reference
Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breast.
10.1038/modpathol.3800514 · 2006 · External reference
Pathological diagnosis of columnar cell lesions of the breast: are there issues of reproducibility?
10.1136/jcp.2004.025239 · 2005 · External reference
Incidence of adjacent synchronous ipsilateral infiltrating carcinoma and/or ductal carcinoma in situ in patients diagnosed with flat epithelial atypia by core needle biopsy (TBCRC 034).
10.1245/s10434-024-16762-z · 2025 · External reference
The 2019 World Health Organization classification of tumours of the breast.
10.1111/his.14091 · 2020 · External reference
Tavassoli FA, Devilee P: Pathology and genetics: tumours of the breast and female genital organs. WHO Classification of Tumours series - volume IV. Lyon, France: IARC Press.
10.1186/bcr788 · 2004 · External reference
Flat epithelial atypia and risk of breast cancer: a Mayo cohort study.
10.1002/cncr.29243 · 2015 · External reference
Pure flat epithelial atypia identified on core needle biopsy does not require excision.
10.1016/j.ejso.2019.10.029 · 2020 · External reference
Flat epithelial atypia on core biopsy and upgrade to cancer: a systematic review and meta-analysis.
10.1245/s10434-017-6059-0 · 2017 · External reference
Atypical lobular hyperplasia and classic lobular carcinoma in situ can be safely managed without surgical excision.
10.1245/s10434-021-10827-z · 2022 · External reference
Rates of atypical ductal hyperplasia have declined with less use of postmenopausal hormone treatment: findings from the Breast Cancer Surveillance Consortium.
10.1158/1055-9965.epi-09-0745 · 2009 · External reference
Atypical hyperplastic lesions of the female breast: a long-term follow-up study.
10.1002/1097-0142(19850601)55:11<2698::aid-cncr2820551127>3.0.co;2-a · 1985 · External reference
Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses’ Health Study.
10.1002/cncr.22408 · 2007 · External reference
Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study.
10.1158/1940-6207.capr-13-0222 · 2014 · External reference
Subsequent breast cancer risk following diagnosis of atypical ductal hyperplasia on needle biopsy.
10.1001/jamaoncol.2016.3022 · 2017 · External reference
Risk assessment tools for women with breast atypia: a systematic review.
10.1016/j.amjsurg.2025.116598 · 2025 · External reference
Model for predicting breast cancer risk in women with atypical hyperplasia.
10.1200/jco.2017.75.9480 · 2018 · External reference
Upgrade rate of percutaneously diagnosed pure atypical ductal hyperplasia: systematic review and meta-analysis of 6458 lesions.
10.1148/radiol.2019190748 · 2020 · External reference
Trends in atypical ductal hyperplasia diagnosis and upgrade: a 20-year experience and impact of MRI use on upgrade rates.
10.1245/s10434-025-16933-6 · 2025 · External reference
Atypical ductal hyperplasia in directional vacuum-assisted biopsy of breast microcalcifications: considerations for surgical excision.
10.1245/s10434-010-1127-8 · 2011 · External reference
Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia.
10.1007/s10549-017-4253-1 · 2017 · External reference
Long-term safety of observation in selected women following core biopsy diagnosis of atypical ductal hyperplasia.
10.1245/s10434-016-5512-9 · 2017 · External reference
Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria.
10.1097/00000478-199212000-00001 · 1992 · External reference
Variability in pathologists’ interpretations of individual breast biopsy slides: a population perspective.
10.7326/m15-0964 · 2016 · External reference
An improved method of preparing nuclei for absorption cytophotometry.
10.1177/33.1.2578144 · 1985 · External reference
Evaluation of 12 strategies for obtaining second opinions to improve interpretation of breast histopathology: simulation study.
10.1136/bmj.i3069 · 2016 · External reference
Understanding diagnostic variability in breast pathology: lessons learned from an expert consensus review panel.
10.1111/his.12387 · 2014 · External reference
Atypical ductal hyperplasia bordering on ductal carcinoma in situ.
10.1177/1066896916662154 · 2017 · External reference
Inter-observer variability between general pathologists and a specialist in breast pathology in the diagnosis of lobular neoplasia, columnar cell lesions, atypical ductal hyperplasia and ductal carcinoma in situ of the breast.
10.1186/1746-1596-9-121 · 2014 · External reference
Atypical ductal hyperplasia: interobserver and intraobserver variability.
10.1038/modpathol.2011.66 · 2011 · External reference
Risk of breast cancer in selected women with atypical ductal hyperplasia who do not undergo surgical excision.
10.1097/sla.0000000000004849 · 2022 · External reference
European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO.
10.1016/j.ejso.2023.107292 · 2024 · External reference
Screening MRI does not increase cancer detection or result in an earlier stage at diagnosis for patients with high-risk breast lesions: a propensity score analysis.
10.1245/s10434-022-12568-z · 2023 · External reference
American Registry of Pathology Expert Opinions: the spectrum of lobular carcinoma in situ: diagnostic features and clinical implications.
10.1016/j.anndiagpath.2020.151481 · 2020 · External reference
Immediate and ipsilateral recurrence rates and treatment recommendations for patients with pleomorphic and florid lobular carcinoma in situ.
10.1007/s10549-025-07771-x · 2025 · External reference
Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy.
10.1245/s10434-011-2034-3 · 2012 · External reference
Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision.
10.1002/cncr.27841 · 2013 · External reference
Atypical lobular hyperplasia and lobular carcinoma in situ at core breast biopsy: use of careful radiologic-pathologic correlation to recommend excision or observation.
10.1148/radiol.13121730 · 2013 · External reference
Evaluating the rate of upgrade to invasive breast cancer and/or ductal carcinoma in situ following a core biopsy diagnosis of non-classic lobular carcinoma in situ.
10.1245/s10434-018-6937-0 · 2019 · External reference
Incidence of adjacent synchronous invasive carcinoma and/or ductal carcinoma in-situ in patients with lobular neoplasia on core biopsy: results from a prospective multi-institutional registry (TBCRC 020).
10.1245/s10434-015-4922-4 · 2016 · External reference
Unresolved reference
2025 · External reference
Unresolved reference
2019 · External reference
Unresolved reference
2019 · External reference
Unresolved reference
2019 · External reference
